Terms: = Lymphoma AND ARID1A, BAF250, 8289, ENSG00000117713, SMARCF1, C1orf4, BM029, B120, RP1-50O24_1, P270, BAF250a AND Prognosis
7624 results:
1. Risk of second primary thyroid cancer in cancer survivors.
Yuan Y; Sun P; Xiao H; Li L; Li J; Ai X
Sci Rep; 2024 May; 14(1):12478. PubMed ID: 38816510
[TBL] [Abstract] [Full Text] [Related]
2. IL-15 gene mutation as a molecular risk factor in acute lymphoid leukemia.
Mohammed SI; Hassan KM; Azeez DM; Qadir FA; Salihi AB
Cell Mol Biol (Noisy-le-grand); 2024 May; 70(5):10-17. PubMed ID: 38814240
[TBL] [Abstract] [Full Text] [Related]
3. 18F-FDG PET/MR for diagnosis of primary central nervous system lymphoma: protocol for a systematic review and meta-analysis.
Qiu X; Zheng H; Zhong F; Shen B
BMJ Open; 2024 May; 14(5):e081458. PubMed ID: 38806425
[TBL] [Abstract] [Full Text] [Related]
4. Real-world experience of commercial relmacabtagene autoleucel (relma-cel) for relapsed/refractory central nervous system lymphoma: a multicenter retrospective analysis of patients in China.
Yu W; Huang L; Mei H; Li Y; Niu T; Zou D; Liu Y; Zhang H; Liu P; Wu J; Wang Z; Li H; Cai Q; Mi JQ
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38802271
[TBL] [Abstract] [Full Text] [Related]
5. Mucosa-associated lymphoid tissue lymphoma of the lacrimal gland: A case report and literature review.
Zhong Q; Yan Y; Li S
Medicine (Baltimore); 2024 May; 103(21):e38303. PubMed ID: 38787969
[TBL] [Abstract] [Full Text] [Related]
6. Combining inotuzumab ozogamicin with PARP inhibitors olaparib and talazoparib exerts synergistic cytotoxicity in acute lymphoblastic leukemia by inhibiting DNA strand break repair.
Ida N; Okura M; Tanaka S; Hosono N; Yamauchi T
Oncol Rep; 2024 Jul; 52(1):. PubMed ID: 38785163
[TBL] [Abstract] [Full Text] [Related]
7. Semimethylation is a feature of diffuse large B-cell lymphoma, and subgroups with poor prognosis are characterized by global hypomethylation and short telomere length.
Carlund O; Thörn E; Osterman P; Fors M; Dernstedt A; Forsell MNE; Erlanson M; Landfors M; Degerman S; Hultdin M
Clin Epigenetics; 2024 May; 16(1):68. PubMed ID: 38773655
[TBL] [Abstract] [Full Text] [Related]
8. Application and prognostic relevance of CD34 detection in immunophenotyping of pediatric acute B lymphoblastic leukemia.
Zha W; Yuan Y; Yang T; Zhu LJ; Kong WY; Zhuo JJ
Eur Rev Med Pharmacol Sci; 2024 May; 28(9):3384-3390. PubMed ID: 38766795
[TBL] [Abstract] [Full Text] [Related]
9. Cancer survival in sub-Saharan Africa (SURVCAN-3): a population-based study.
Joko-Fru WY; Bardot A; Bukirwa P; Amidou S; N'da G; Woldetsadik E; Chesumbai G; Korir A; Kamaté B; Koon M; Hansen R; Finesse A; Somdyala N; Chokunonga E; Chigonzoh T; Liu B; Kantelhardt EJ; Parkin DM; Soerjomataram I
Lancet Glob Health; 2024 Jun; 12(6):e947-e959. PubMed ID: 38762297
[TBL] [Abstract] [Full Text] [Related]
10. Sintilimab (anti-PD-1 antibody) plus chidamide (histone deacetylase inhibitor) in relapsed or refractory extranodal natural killer T-cell lymphoma (SCENT): a phase Ib/II study.
Gao Y; He H; Li X; Zhang L; Xu W; Feng R; Li W; Xiao Y; Liu X; Chen Y; Wang X; Bai B; Wu H; Cai Q; Li Z; Li J; Lin S; He Y; Ping L; Huang C; Mao J; Chen X; Zhao B; Huang H
Signal Transduct Target Ther; 2024 May; 9(1):121. PubMed ID: 38755119
[TBL] [Abstract] [Full Text] [Related]
11. Foetal haemoglobin elevation, unfavourable prognosis, and protective role of genetic variants
Borrayo-LóPez FJ; Ibarra-Cortés B; Perea-Díaz F; MuñOz-Zúñiga AI; Montoya-Fuentes H; Soto-Padilla JM; Rizo-De La Torre LDC
J Genet; 2024; 103():. PubMed ID: 38736250
[TBL] [Abstract] [Full Text] [Related]
12. The association of the hepatitis B virus infection and diffuse large B-cell lymphoma.
Yu G; Han J; Xu J
Saudi Med J; 2024 May; 45(5):490-494. PubMed ID: 38734435
[TBL] [Abstract] [Full Text] [Related]
13. [The value of minimal residual disease and IKZF1 deletion for predicting prognosis in adult patients with B-cell acute lymphoblastic leukemia].
Deng SY; Ou JW; Huang ZC; Chen JJ; Cai ZH; Liu QF; Zhou HS
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):257-263. PubMed ID: 38716597
[No Abstract] [Full Text] [Related]
14. [Efficacy of allogeneic hematopoietic stem cell transplantation based on a total body irradiation conditioning treatment regimen for adult acute lymphocytic leukemia].
Xiao QQ; Yu XL; Song XC; Hou YX; Deng L; Li WJ; Zhou F
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):249-256. PubMed ID: 38716596
[No Abstract] [Full Text] [Related]
15. [The clinical features, survival analysis, and geriatric assessment of 85 patients with follicular lymphoma: a single-center study].
Yin JJ; Qian L; Bai JF; Feng R; Li JT; Wang T; Zhang CL; Liu H
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):233-241. PubMed ID: 38716594
[No Abstract] [Full Text] [Related]
16. Clinical characteristics, radiological features and outcomes in pulmonary involvement of cryoglobulinemia.
Han HX; Su W; Tian X; Zhou DB; Li J; Cao XX
Orphanet J Rare Dis; 2024 May; 19(1):185. PubMed ID: 38698461
[TBL] [Abstract] [Full Text] [Related]
17. p53-Armed Oncolytic Virotherapy Improves Radiosensitivity in Soft-Tissue Sarcoma by Suppressing BCL-xL Expression.
Komatsubara T; Tazawa H; Hasei J; Omori T; Sugiu K; Mochizuki Y; Demiya K; Yoshida A; Fujiwara T; Kunisada T; Urata Y; Kagawa S; Ozaki T; Fujiwara T
Acta Med Okayama; 2024 Apr; 78(2):151-161. PubMed ID: 38688833
[TBL] [Abstract] [Full Text] [Related]
18. [Obesity and risk of relapse in patients with Acute Lymphoblastic Leukemia: A retrospective study].
Ramos-Peñafiel CO; Bejarano-Rosales MP; Gallardo-Rodríguez AG; Pérez-Sámano D; Leyton-Rivera HR; Olarte-Carrillo I; Martínez-Tovar A; Tarlovsky VF; Barranco-Lampón G; Alvarez-Altamirano K
Rev Med Chil; 2023 May; 151(5):600-609. PubMed ID: 38687542
[TBL] [Abstract] [Full Text] [Related]
19. [Expression of CD30 in Patients with Diffuse Large B-Cell lymphoma and Clinical Significance].
Qu Y; Lu XZ; Wang RX; Hei XF; Li J; Xiao BT; Jia ZX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):450-457. PubMed ID: 38660851
[TBL] [Abstract] [Full Text] [Related]
20. [Effect of L-Type Amino Acid Transporter 1 Expression on Clinicopathological Features and prognosis of Non-Hodgkin's lymphoma].
Zhao ZF; Hao XJ; Yang YM; Xu WG; Zhang YX; Yuan XH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):434-438. PubMed ID: 38660848
[TBL] [Abstract] [Full Text] [Related]
[Next]
